IKBKG and incontinentia pigmenti: IP arises from inherited mutations (10%–25% of patients) or sporadic de novo mutations (>75%) in the inhibitor of IKBKG (kappa B kinase gamma, previously known as NEMO) gene, located at Xq28 (3, 4).